Bhojwani Gary C. sold $4.4M of CNO

Bhojwani Gary C. (Chief Executive Officer) sold 86,048 shares of CNO Financial Group, Inc. (CNO) at an average of $51.48 ($51.48–$51.48, $4.43M total) across 2 trades on 2026-06-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bhojwani Gary C.
Published Jul 1, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CNO
Neutral
medium confidence
Mentioned
$CNO
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNONeutralLow
01

Why it matters

The newest concrete fact is the CEO’s $4.43M open-market sale executed under a 10b5-1 plan; this can influence short-term sentiment but is less likely to change fundamentals immediately.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 framing typically limits interpretive weight.

03

What to watch

The filing does not disclose reasons for the sale, and the CEO’s remaining holdings (174,264 shares after) may still indicate continued long-term exposure.

Relevance 5/10Novelty 5/10Timing: new Form 4 filed 2026-07-01 (covering 2026-06-30 sale)

Background

The article is a SEC Form 4 insider transaction disclosure for CNO Financial Group, Inc. (CNO).

Company-level read

Ticker impact

$CNONeutralMedium confidence
Context

CNO CEO Gary C. Bhojwani sold $4.43M of CNO shares in an open-market transaction under a pre-arranged 10b5-1 plan on 2026-06-30.

Expected impact

Likely limited immediate price impact; any effect is more sentiment/positioning than fundamentals.

Evidence & confidence

The filing is a primary-source Form 4 showing a sizable sale ($4.43M) while explicitly stating a pre-arranged 10b5-1 plan, which typically dampens interpretive value versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity with no sector-wide regulatory or earnings signal.

None indicated; US-listed insurer insider transaction only.

None indicated; no cross-border deal, regulation, or macro linkage described.

Counterpoint

Because the sale is executed under a pre-arranged 10b5-1 plan, it may reflect routine liquidity/compensation rather than a bearish view on CNO’s prospects.

Key entities

  • CNO Financial Group, Inc.

    Subject of the Form 4 insider transaction; CEO sold 86,048 shares for ~$4.43M.

  • Gary C. Bhojwani

    CNO CEO and director who executed the open-market sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNOMed

CNO Financial Group Inc (CNO) (Q3 2026) Earnings Call Highlights: Raised Guidance

CNO Financial Group reported Q3 2026 earnings, raising guidance. Life NAP decreased 9% due to a discontinued program. Medicare Supplement results were impacted by higher morbidity. Free cash flow guidance tightened to $220-$240M. Net investment income increased 72%, but $12M is not expected to continue. The company discussed reinsurance deals, expense management, and economic pressures. CEO Gary Bhojwani noted structural demand drivers for their services.

$CNOHighAI 8/10

CNO Financial (CNO) Q3 2026 Earnings Call Transcript

CNO Financial reported Q3 2026 earnings, highlighting 4% growth in agent count and strong sales across divisions. Medicare Supplement NAP surged 41%, and Life NAP rose 20% excluding a discontinued program. Annuity premiums increased 9%, and brokerage assets grew 15%. Operating EPS reached $1.90, up 47% YoY. The company ceded $270M in life reserves to CNO Bermuda Re for capital optimization.

$CNOMedAI 8/10

What CNO Financial Group (CNO) Said on Its Q3 Earnings Call

CNO Financial Group reported Q3 operating EPS of $1.42, up 48% YoY. Sales grew in life, hospital indemnity, and accident products. Investment income rose 13%, and the company returned $77M to shareholders. CNO updated its 2026 outlook, lowering the expense ratio and raising EPS estimates. The company also completed a reinsurance transaction with its Bermuda affiliate.